D

Deciphera Pharmaceuticals Inc
F:D05

Watchlist Manager
Deciphera Pharmaceuticals Inc
F:D05
Watchlist
Price: 47.91 EUR -0.73% Market Closed
Market Cap: 3.9B EUR

Intrinsic Value

The intrinsic value of one D05 stock under the Base Case scenario is 13.39 EUR. Compared to the current market price of 47.91 EUR, Deciphera Pharmaceuticals Inc is Overvalued by 72%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

D05 Intrinsic Value
13.39 EUR
Overvaluation 72%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation History
Deciphera Pharmaceuticals Inc

What is Valuation History?
Compare D05 to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about D05?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Deciphera Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Deciphera Pharmaceuticals Inc

Current Assets 349.9m
Cash & Short-Term Investments 272.5m
Receivables 32.7m
Other Current Assets 44.7m
Non-Current Assets 71m
Long-Term Investments 26.8m
PP&E 36.1m
Other Non-Current Assets 8.1m
Efficiency

Free Cash Flow Analysis
Deciphera Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Deciphera Pharmaceuticals Inc

Revenue
174.9m USD
Cost of Revenue
-5.3m USD
Gross Profit
169.6m USD
Operating Expenses
-376.1m USD
Operating Income
-206.5m USD
Other Expenses
16.1m USD
Net Income
-190.4m USD
Fundamental Scores

D05 Profitability Score
Profitability Due Diligence

Deciphera Pharmaceuticals Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROE is Increasing
28/100
Profitability
Score

Deciphera Pharmaceuticals Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

D05 Solvency Score
Solvency Due Diligence

Deciphera Pharmaceuticals Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
63/100
Solvency
Score

Deciphera Pharmaceuticals Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

D05 Price Targets Summary
Deciphera Pharmaceuticals Inc

There are no price targets for D05.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Deciphera Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for D05 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one D05 stock?

The intrinsic value of one D05 stock under the Base Case scenario is 13.39 EUR.

Is D05 stock undervalued or overvalued?

Compared to the current market price of 47.91 EUR, Deciphera Pharmaceuticals Inc is Overvalued by 72%.

Back to Top